Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Disitamab Vedotin
Ovarian Cancer
Second Xiangya Hospital of Central South UniversityP2B (60)
dll3-car-nk cells
Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and HospitalP2B (60)
Docetaxel
Gastroesophageal Cancer
Oscotec Inc.P2B (60)
Docetaxel
Estrogen-Receptor Positive Breast Cancer
Dana-Farber Cancer InstituteP2B (60)
Docetaxel
Metastatic Melanoma
OncoC4, Inc.P2B (60)
Docetaxel
Myelosuppression, Non-Human Animal
The First Affiliated Hospital of Xiamen UniversityP2B (60)
Docetaxel
Pancreatic Neoplasm
Hummingbird BioscienceP2B (60)
Donq52
Celiac Disease
Chugai PharmaceuticalP2B (60)
Dostarlimab
Rectal Neoplasm
GlaxoSmithKlineP2B (60)
Durvalumab
Biliary Tract Cancer
Replimune, Inc.P2B (60)
Durvalumab
Gallbladder Cancer
Lisata Therapeutics, Inc.P2B (60)
Durvalumab
Female Reproductive Organ Cancer
Institute of Cancer Research, United KingdomP2B (60)
Durvalumab
Kidney Cancer
Ajjai Alva, MDP2B (60)
Durvalumab
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)P2B (60)
Durvalumab
Lung Carcinoma
University of British ColumbiaP2B (60)
Durvalumab
Cutaneous Neuroendocrine Carcinoma
Ariceum Therapeutics GmbHP2B (60)
Durvalumab
Metastatic Prostate Carcinoma
Rahul AggarwalP2B (60)
Durvalumab
Primary Central Nervous System Lymphoma
Washington University School of MedicineP2B (60)
Durvalumab
Gastric Adenocarcinoma
University of California, IrvineP2B (60)
Dynamos
Metabolic Dysfunction-Associated Steatohepatitis
Yale UniversityP2B (60)
e7 tcr-t cells
Cervical Carcinoma
Christian HinrichsP2B (60)
e7 tcr-t cells
Oropharynx Cancer
Christian HinrichsP2B (60)
e7 tcr-t cells
Penile Cancer
Christian HinrichsP2B (60)
e7 tcr-t cells
Vaginal Cancer
Christian HinrichsP2B (60)
e7 tcr-t cells
Vulva Cancer
Christian HinrichsP2B (60)
Showing 1751 to 1775 of 13,155 assets
PreviousPage 71 of 527Next